This study aims to estimate lifetime AAS use among patients in substance use disorder (SUD) treatment, compare characteristics of AAS and non-AAS users and identify whether AAS use was addressed during treatment. Evidence indicates that AAS use among people who use psychoactive substances is higher than in the general population. Anabolic androgenic steroid (AAS) use […]